Cite
HARVARD Citation
Tsuda, H. et al. (2021). Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study. Japanese journal of clinical oncology. pp. 434-443. [Online].